$NAVB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NAVIDEA BIOPHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NAVIDEA BIOPHARMACEUTICALS, INC.. Get notifications about new insider transactions in NAVIDEA BIOPHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Buy | W | 0.00 | 500 | 0 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Gift | G | 0.00 | 1,000 | 0 | 136,200 | 137.2 K to 136.2 K (-0.73 %) |
Mar 28 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.35 | 11,000 | 3,795 | 137,200 | 126.2 K to 137.2 K (+8.72 %) |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Rash Douglas L | Vice President, Mar ... | Option Exercise | A | 0.36 | 20,000 | 7,200 | 20,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.36 | 10,000 | 3,600 | 10,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Option Exercise | A | 0.36 | 10,000 | 3,600 | 10,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.36 | 50,000 | 18,000 | 50,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Option Exercise | A | 0.36 | 10,000 | 3,600 | 10,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.36 | 200,000 | 72,000 | 200,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.36 | 20,000 | 7,200 | 20,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 0.36 | 50,000 | 18,000 | 50,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Option Exercise | A | 0.36 | 10,000 | 3,600 | 10,000 | |
Jan 07 2008 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Option Exercise | A | 0.36 | 10,000 | 3,600 | 10,000 | |
Dec 28 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | G | 0.32 | 50,000 | 16,000 | 450,000 | |
Dec 28 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.32 | 500,000 | 160,000 | 500,000 | |
Jul 30 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Johnson Owen E | Director | Option Exercise | A | 0.35 | 20,000 | 7,000 | 20,000 | |
Jul 30 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 0.35 | 20,000 | 7,000 | 20,000 | |
Jul 26 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | G | 0.31 | 20,000 | 6,200 | 20,000 | |
Jul 26 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | G | 0.31 | 180,000 | 55,800 | 320,000 | |
Jul 09 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.31 | 500,000 | 155,000 | 500,000 | |
Jul 09 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.31 | 3,225,806 | 1,000,000 | 3,225,806 | |
May 29 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.22 | 10,000 | 2,200 | 126,200 | 116.2 K to 126.2 K (+8.61 %) |
May 25 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.22 | 20,000 | 4,400 | 116,200 | 96.2 K to 116.2 K (+20.79 %) |
May 23 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.23 | 5,000 | 1,150 | 96,200 | 91.2 K to 96.2 K (+5.48 %) |
May 23 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.22 | 10,000 | 2,200 | 91,200 | 81.2 K to 91.2 K (+12.32 %) |
May 22 2007 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.21 | 30,000 | 6,300 | 50,000 | 20 K to 50 K (+150.00 %) |
May 21 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.23 | 5,000 | 1,150 | 81,200 | 76.2 K to 81.2 K (+6.56 %) |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Rash Douglas L | Vice President, Mar ... | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.27 | 50,000 | 13,500 | 50,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | KREVANS JULIUS R | Director | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.27 | 300,000 | 81,000 | 300,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | BOSCH CARL M | VP - Instrument Dev ... | Option Exercise | A | 0.27 | 50,000 | 13,500 | 50,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 0.27 | 30,000 | 8,100 | 30,000 | |
Jan 17 2007 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Option Exercise | A | 0.27 | 20,000 | 5,400 | 20,000 | |
Aug 25 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.27 | 1,000 | 270 | 76,200 | 75.2 K to 76.2 K (+1.33 %) |
Aug 21 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.28 | 5,000 | 1,375 | 75,200 | 70.2 K to 75.2 K (+7.12 %) |
Aug 21 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.26 | 1,000 | 260 | 70,200 | 69.2 K to 70.2 K (+1.45 %) |
Aug 16 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.28 | 5,000 | 1,375 | 69,200 | 64.2 K to 69.2 K (+7.79 %) |
Aug 16 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.27 | 200 | 54 | 64,200 | 64 K to 64.2 K (+0.31 %) |
Aug 10 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.27 | 5,000 | 1,350 | 64,000 | 59 K to 64 K (+8.47 %) |
Aug 10 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.26 | 5,000 | 1,300 | 59,000 | 54 K to 59 K (+9.26 %) |
Aug 09 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.26 | 2,000 | 520 | 49,000 | 47 K to 49 K (+4.26 %) |
Jun 20 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.29 | 5,000 | 1,450 | 47,000 | 42 K to 47 K (+11.90 %) |
Jun 20 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.28 | 5,000 | 1,400 | 42,000 | 37 K to 42 K (+13.51 %) |
Jun 19 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.30 | 2,000 | 598 | 37,000 | 35 K to 37 K (+5.71 %) |
Jun 19 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.29 | 1,000 | 290 | 35,000 | 34 K to 35 K (+2.94 %) |
Jun 15 2006 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.30 | 20,000 | 5,980 | 31,000 | 11 K to 31 K (+181.82 %) |
Jun 15 2006 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.30 | 20,000 | 5,980 | 20,000 | 0 to 20 K |
Jun 14 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.30 | 2,000 | 598 | 34,000 | 32 K to 34 K (+6.25 %) |
Jun 14 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.29 | 1,000 | 290 | 32,000 | 31 K to 32 K (+3.23 %) |
Jun 14 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.29 | 1,000 | 290 | 31,000 | 30 K to 31 K (+3.33 %) |
Jun 07 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.26 | 1,000 | 260 | 30,000 | 29 K to 30 K (+3.45 %) |
Jun 01 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.25 | 5,100 | 1,275 | 29,000 | 23.9 K to 29 K (+21.34 %) |
Jun 01 2006 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.25 | 900 | 225 | 23,900 | 23 K to 23.9 K (+3.91 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.27 | 9,400 | 2,538 | 175,511 | 166.1 K to 175.5 K (+5.66 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.26 | 600 | 156 | 166,111 | 165.5 K to 166.1 K (+0.36 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 15,886 | 0 | 165,511 | 149.6 K to 165.5 K (+10.62 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 67,550 | 0 | 149,625 | 82.1 K to 149.6 K (+82.30 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 24,200 | 0 | 82,075 | 57.9 K to 82.1 K (+41.81 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.26 | 10,000 | 2,600 | 438,500 | 428.5 K to 438.5 K (+2.33 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.25 | 30,000 | 7,500 | 428,500 | 398.5 K to 428.5 K (+7.53 %) |
May 31 2006 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 24,200 | 0 | 398,500 | 422.7 K to 398.5 K (-5.73 %) |
May 15 2006 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | P | 0.27 | 4,500 | 1,215 | 100,000 | 95.5 K to 100 K (+4.71 %) |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | Rash Douglas L | Vice President, Mar ... | Option Exercise | A | 0.26 | 20,000 | 5,200 | 20,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.26 | 40,000 | 10,400 | 40,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | KREVANS JULIUS R | Director | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.26 | 200,000 | 52,000 | 200,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.26 | 20,000 | 5,200 | 20,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BOSCH CARL M | VP - Instrument Dev ... | Option Exercise | A | 0.26 | 40,000 | 10,400 | 40,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 29 2005 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Option Exercise | A | 0.26 | 30,000 | 7,800 | 30,000 | |
Dec 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Sell | S | 0.26 | 2,000 | 520 | 422,700 | 424.7 K to 422.7 K (-0.47 %) |
Dec 05 2005 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | P | 0.25 | 5,000 | 1,250 | 95,500 | 90.5 K to 95.5 K (+5.52 %) |
Nov 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.27 | 8,500 | 2,295 | 424,700 | 416.2 K to 424.7 K (+2.04 %) |
Nov 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.28 | 10,700 | 2,943 | 416,200 | 405.5 K to 416.2 K (+2.64 %) |
Nov 15 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.28 | 5,000 | 1,400 | 405,500 | 400.5 K to 405.5 K (+1.25 %) |
May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.38 | 15,000 | 5,700 | 400,500 | 385.5 K to 400.5 K (+3.89 %) |
May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.34 | 5,000 | 1,700 | 385,500 | 380.5 K to 385.5 K (+1.31 %) |
May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.32 | 5,000 | 1,575 | 380,500 | 375.5 K to 380.5 K (+1.33 %) |
May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.33 | 10,000 | 3,300 | 375,500 | 365.5 K to 375.5 K (+2.74 %) |
May 19 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.33 | 15,000 | 4,950 | 365,500 | 350.5 K to 365.5 K (+4.28 %) |
May 10 2005 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Buy | P | 0.35 | 15,000 | 5,250 | 90,500 | 75.5 K to 90.5 K (+19.87 %) |
Apr 18 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.40 | 4,000 | 1,600 | 57,875 | 53.9 K to 57.9 K (+7.42 %) |
Apr 18 2005 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.42 | 3,000 | 1,260 | 53,875 | 50.9 K to 53.9 K (+5.90 %) |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | A | 0.68 | 40,000 | 27,200 | 40,000 | |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.68 | 60,000 | 40,800 | 60,000 | |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | KREVANS JULIUS R | Director | Option Exercise | A | 0.68 | 60,000 | 40,800 | 60,000 | |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | KATZ NANCY E | Director | Option Exercise | A | 0.68 | 40,000 | 27,200 | 40,000 | |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Option Exercise | A | 0.68 | 40,000 | 27,200 | 40,000 | |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | AVITAL REUVEN | Director | Option Exercise | A | 0.68 | 40,000 | 27,200 | 40,000 | |
Feb 16 2005 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Option Exercise | A | 0.68 | 40,000 | 27,200 | 40,000 | |
Jan 20 2005 | NAVB | NAVIDEA BIOPHARMAC ... | GREAT POINT PARTNERS LLC | 10% Owner | Buy | P | 0.58 | 35,000 | 20,125 | 335,000 | 300 K to 335 K (+11.67 %) |
Jan 20 2005 | NAVB | NAVIDEA BIOPHARMAC ... | GREAT POINT PARTNERS LLC | 10% Owner | Buy | P | 0.60 | 200,000 | 119,400 | 300,000 | 100 K to 300 K (+200.00 %) |
Jan 20 2005 | NAVB | NAVIDEA BIOPHARMAC ... | GREAT POINT PARTNERS LLC | 10% Owner | Buy | P | 0.55 | 100,000 | 55,300 | 100,000 | 0 to 100 K |
Dec 16 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.46 | 125,000 | 57,500 | 125,000 | |
Dec 16 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.40 | 250,000 | 100,000 | 250,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.39 | 50,000 | 19,500 | 50,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.39 | 50,000 | 19,500 | 50,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.39 | 200,000 | 78,000 | 200,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.39 | 40,000 | 15,600 | 40,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BOSCH CARL M | VP - Instrument Dev ... | Option Exercise | A | 0.39 | 50,000 | 19,500 | 50,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BOSCH CARL M | VP - Instrument Dev ... | Option Exercise | A | 0.39 | 50,000 | 19,500 | 50,000 | |
Dec 14 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Option Exercise | A | 0.39 | 40,000 | 15,600 | 40,000 | |
Nov 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.40 | 5,000 | 1,975 | 50,875 | 45.9 K to 50.9 K (+10.90 %) |
Sep 20 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.44 | 3,000 | 1,320 | 23,000 | 20 K to 23 K (+15.00 %) |
Sep 20 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.45 | 4,000 | 1,800 | 20,000 | 16 K to 20 K (+25.00 %) |
Sep 07 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.42 | 3,000 | 1,260 | 16,000 | 13 K to 16 K (+23.08 %) |
Sep 07 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.43 | 5,000 | 2,150 | 13,000 | 8 K to 13 K (+62.50 %) |
Sep 07 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.43 | 5,000 | 2,150 | 8,000 | 3 K to 8 K (+166.67 %) |
Sep 07 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Buy | P | 0.44 | 3,000 | 1,320 | 3,000 | 0 to 3 K |
Aug 24 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Buy | P | 0.40 | 20,000 | 7,900 | 50,000 | 30 K to 50 K (+66.67 %) |
Aug 20 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.39 | 10,000 | 3,900 | 350,500 | 340.5 K to 350.5 K (+2.94 %) |
Aug 16 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Blair Anthony K | VP-Manufacturing & ... | Buy | P | 0.40 | 30,000 | 12,000 | 30,000 | 0 to 30 K |
Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.49 | 50,000 | 24,500 | 50,000 | |
Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.49 | 150,000 | 73,500 | 150,000 | |
Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.49 | 50,000 | 24,500 | 50,000 | |
Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BOSCH CARL M | VP - Instrument Dev ... | Option Exercise | A | 0.49 | 50,000 | 24,500 | 50,000 | |
Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Bland Kirby I | Director | Option Exercise | A | 0.49 | 40,000 | 19,600 | 40,000 | |
Jul 29 2004 | NAVB | NAVIDEA BIOPHARMAC ... | Aschinger Carl J Jr | Director | Option Exercise | A | 0.49 | 40,000 | 19,600 | 40,000 | |
May 26 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.43 | 10,000 | 4,300 | 340,500 | 330.5 K to 340.5 K (+3.03 %) |
May 25 2004 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.49 | 5,000 | 2,450 | 11,000 | 6 K to 11 K (+83.33 %) |
May 25 2004 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Buy | P | 0.47 | 5,000 | 2,350 | 6,000 | 1,000 to 6 K (+500.00 %) |
May 25 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.47 | 14,000 | 6,580 | 330,500 | 316.5 K to 330.5 K (+4.42 %) |
May 25 2004 | NAVB | NAVIDEA BIOPHARMAC ... | KATZ NANCY E | Director | Buy | P | 0.45 | 2,400 | 1,080 | 2,400 | 0 to 2.4 K |
May 19 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Buy | P | 0.50 | 15,000 | 7,500 | 316,500 | 301.5 K to 316.5 K (+4.98 %) |
Apr 12 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Gift | G | 0.00 | 15,000 | 0 | 301,500 | 316.5 K to 301.5 K (-4.74 %) |
Mar 10 2004 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
Mar 10 2004 | NAVB | NAVIDEA BIOPHARMAC ... | KREVANS JULIUS R | Director | Option Exercise | A | 0.50 | 40,000 | 20,000 | 40,000 | |
Mar 10 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.50 | 375,000 | 187,500 | 375,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | WHITLEY J FRANK | Director | Option Exercise | A | 0.30 | 40,000 | 12,000 | 40,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.30 | 40,000 | 12,000 | 40,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | MILLER FRED B | Director | Option Exercise | A | 0.30 | 40,000 | 12,000 | 40,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | LINDER RICHARD N JR | VP Sales & Marketin ... | Option Exercise | A | 0.30 | 200,000 | 60,000 | 200,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | LARSON BRENT L | VP Finance and CFO | Option Exercise | A | 0.30 | 70,000 | 21,000 | 70,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | KREVANS JULIUS R | Director | Option Exercise | A | 0.30 | 40,000 | 12,000 | 40,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | KREVANS JULIUS R | Director | Option Exercise | A | 0.30 | 40,000 | 12,000 | 40,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | KATZ NANCY E | Director | Option Exercise | A | 0.30 | 40,000 | 12,000 | 40,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BUPP DAVID C | CEO and President | Option Exercise | A | 0.30 | 150,000 | 45,000 | 150,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.30 | 70,000 | 21,000 | 70,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BROWN RODGER A | Vice President | Option Exercise | A | 0.30 | 70,000 | 21,000 | 70,000 | |
Jan 09 2004 | NAVB | NAVIDEA BIOPHARMAC ... | BOSCH CARL M | VP - Instrument Dev ... | Option Exercise | A | 0.30 | 70,000 | 21,000 | 70,000 |